Overview

Gender

male

Ehsan Sarafraz-Yazd is the Co-Founder and Chief Executive Officer of NomoCan Pharmaceuticals. He has 14 years of experience in the field of cancer. Prior to joining NomoCan, he was an Assistant Professor and translational research director at the Division of Gynecologic Oncology, State University of New York, Downstate Medical Center. He has several patents related to anti-cancer peptides which are at various stages of development by other companies. His research has been recognized by various awards including the "Outstanding Clinical Scholar" award from the AACR/GlaxoSmithKline as well as by the Robert Furchgott Society (Nobel Prize in Medicine,’98). Dr. Yazdi received his Ph.D. in Cellular and Molecular Biology and M.P.H. in Health Policy and Management from SUNY Health Science Center- NY and his M.Sc. in Applied Genetics from the University of Birmingham and Imperial College of London- U.K.